Compare Becton Dickinson and Co (BDX) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Sprott Uranium Miners ETF — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Sprott Uranium Miners ETF trades at $55.97. The key difference: Becton Dickinson and Co pays a 2.34% dividend while Sprott Uranium Miners ETF pays none, and Becton Dickinson and Co is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals.
| BDX | URNM | |
|---|---|---|
Market Cap | $48.93B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $185.39 | $83.99 |
52-Week Low | $138.62 | $44.14 |
Enterprise Value | $65.03B | — |
Dividend Yield | 2.34% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.
The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.
URNM trades at $54.53, up 2.77% today, with a bullish technical signal from moving averages but a neutral reading from oscillators. The ETF, focused on uranium miners, benefits from growing nuclear energy demand driven by AI power needs and government support, as highlighted in recent news. However, key financial ratios like P/E and P/S are unavailable, limiting fundamental clarity.
The outlook for URNM is positive due to structural tailwinds in nuclear energy, but risks include high volatility from commodity prices and concentrated miner exposure. Investors should weigh the bullish technical setup against the lack of transparent valuation metrics and potential sector-specific headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
